Published online Sep 15, 2000. doi: 10.3748/wjg.v6.iSuppl3.10
Revised: June 25, 2000
Accepted: July 10, 2000
Published online: September 15, 2000
AIM: To provide evidence that UBT is the most cost effective tool for evaluation of H. pylori eradication.
METHODS: Data on twenty six consecutive patients at Atlanta VA Hospital who underwent UBT were retrospectively reviewed. All patients had endoscopic diagnosis of peptic ulcers and biopsy proven H. pylori infection. Eight to ten weeks after completion of triple therapy (amoxicillin, biaxin and prilosec), all patients had C14 UBT (PY test kit, Charlottesville, Virginia). Ten patients had repeated endoscopic examinations and gastric biopsies. Twelve patients had serology tests for H. pylori.
RESULTS: UBT was negative in all patients (two patients had indeterminate result on the first time, but shown to be negative on the second UBT). Biopsies from all ten patients who were re endoscoped were negative for H. pylori. Serology tests on all the twelve patients were positive. Cure of H. pylori could not be determined on the titer change. All patients spent about 30 min in nuclear medicine laboratory, the endoscopic patients spent 2 h to 4 h in endoscopic laboratory; the cost for a UBT was about ＄50, the cost for an endoscopy with biopsy was above ＄200.
CONCLUSION: The C 14 UBT is a rapid, economic and accurate test to monitor H. pylori eradication. The test should be considered a gold standard test for evaluating the effectiveness of treatment of H. pylori infection, unless patients need repeated endoscopy to rule out gastric cancer.